⌕
HUTCHMED (China) · HCM · Nasdaq
Tenet 61 · Solid
Compare
$14.73−1.14%At closeTenet 61 · Solid
$14.73−0.17 (−1.14%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

HUTCHMED (China) (HCM) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 35% below its peak, net margin 83.4%. Worth your attention in FY25: Share count (+10.1%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼13.0%
548.5
FY21→FY25CAGR +11.4%/yr
Net income ($M)▲1099.2%
457.7
one-off year: see footnoteCAGR —
Free cash flow ($M)▼352.0%
−78.8
FY21→FY25CAGR —
Diluted EPS▲1200.0%
0.52
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+10.1%

792.7mn → 872.9mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$14.1M

−21.1% YoY in FY25 · 2.6% of revenue.

Returns vs FCF
n/m

$0.0M returned vs $−78.8M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)548.5Revenue−336.3COGS212.2Gross profit−148.3R&D−103.0SG&A−39.2Op income496.9Tax & other457.7Net income

83¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~4%FY21FY25

Over this window: gross 27.5% → 38.7%. Net margin 83.4% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemFY25 †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
548,512.0548,512.0630,201.0837,999.0426,409.0356,128.0▼13.0%+11.4%
Cost of revenue
336,349.0336,349.0348,884.0384,447.0311,103.0258,234.0▼3.6%+6.8%
Gross profit
212,163.0212,163.0281,317.0453,552.0115,306.097,894.0▼24.6%+21.3%
Research & development
148,295.0148,295.0212,109.0302,001.0386,893.0299,086.0▼30.1%−16.1%
Selling, general & admin
103,028.0103,028.0112,913.0133,176.0136,106.0127,125.0▼8.8%−5.1%
Total operating expenses
251,323.0251,323.0325,022.0435,177.0522,999.0426,211.0▼22.7%−12.4%
Operating incomefeeds ROC rank
−39,160.0−39,160.0−43,705.018,375.0−407,693.0−328,317.0▲10.4%—
Other income, net
537,851.0537,851.042,598.039,933.0−2,729.0112,577.0——
Pretax income
498,691.0498,691.0−1,107.058,308.0−410,422.0−215,740.0——
Income tax
63,610.063,610.07,192.04,509.0−283.011,918.0▲784.5%+52.0%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
457,732.0457,732.038,170.0101,094.0−360,386.0−167,041.0▲1099.2%—
Per share
Diluted EPSbuyback-sensitive
0.520.520.040.12−0.43−0.25▲1200.0%—
Diluted shares (mn)
872.89872.89872.83869.20847.14792.68▲0.0%+2.4%
Margins
Gross margin19th pct in Healthcare
38.7%38.7%44.6%54.1%27.0%27.5%▼6.0pp+11.2pp
Operating margin
−7.1%−7.1%−6.9%2.2%−95.6%−92.2%▼0.2pp+85.1pp
Net margin
83.4%83.4%6.1%12.1%−84.5%−46.9%▲77.4pp+130.4pp
† FY25 = fiscal 2025, through 2025-12-31; the trailing year is not available.FY24 effective tax rate was −650% vs a 0% norm for this window, likely a one-time item; see the filing.FY25 effective tax rate was 13% vs a 0% norm for this window, likely a one-time item; see the filing.
FY14 – FY20 · 7 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 7 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-05 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was HUTCHMED (China)'s revenue last fiscal year?

HUTCHMED (China) reported revenue of $548.5M in fiscal 2025, down 13.0% from fiscal 2024.

What was HUTCHMED (China)'s net income?

HUTCHMED (China) reported net income of $457.7M in fiscal 2025, a net margin of 83.4%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.